News
LH-WI
207.45
0.00%
0.00
Illumina nominates former LabCorp CEO David King to board as three directors retire
Reuters · 2d ago
Labcorp to report first-quarter results, host earnings webcast
Reuters · 4d ago
LABCORP TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS ON APRIL 30, 2026
Reuters · 4d ago
Labcorp SVP, Chief Accounting Officer Peter J. Wilkinson disposes of common shares worth $0.85m
Reuters · 5d ago
Labcorp EVP Jonathan C. Meltzer disposes of common shares worth $0.42 million
Reuters · 5d ago
Labcorp enters USD 750 million term loan credit agreement with Wells Fargo-led lenders
Reuters · 03/20 21:02
LABCORP - ENTERS $750 MLN SENIOR UNSECURED TERM LOAN MATURING MARCH 20, 2028 - SEC FILING
Reuters · 03/20 21:02
Labcorp completes acquisition of select Lab Alliance assets from Crouse Health
Reuters · 03/19 12:36
Illumina and Labcorp expand precision oncology testing collaboration
Reuters · 03/18 13:20
ILLUMINA INC - OFFERING TO PROVIDE PHARMACEUTICAL COMPANIES OPPORTUNITIES FOR COMPANION DIAGNOSTIC DEVELOPMENT
Reuters · 03/18 13:15
ILLUMINA INC - NEW TEST DEVELOPMENT TO INCLUDE IVD TESTS FOR CGP AND WGS IN ONCOLOGY
Reuters · 03/18 13:15
LABCORP CEO ADAM SCHECHTER REPORTS OPEN MARKET SALE OF 8,705 CO'S COMMON SHARES ON MARCH 3 AT $279.9595/SHARE - SEC FILING
Reuters · 03/05 14:17
Labcorp President and CEO Adam H. Schechter Disposes of Common Shares
Reuters · 03/05 13:57
Labcorp EVP Corporate Affairs Sandra D. van der Vaart Disposes of Common Shares
Reuters · 03/03 15:42
Labcorp EVP Brian J. Caveney Disposes of Common Shares
Reuters · 02/26 13:26
Labcorp FY 2025 restructuring and other charges rise 176.5% to USD 127.2 million
Reuters · 02/24 18:52
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies
Reuters · 02/24 07:56
LABCORP <LH.N>: PIPER SANDLER RAISES TARGET PRICE TO $300 FROM $270
Reuters · 02/24 04:13
Labcorp SVP and Chief Accounting Officer Peter J. Wilkinson Disposes of Common Shares
Reuters · 02/23 14:14
Labcorp Expands Collaboration With PathAI to Deploy AISight Dx Nationwide
Reuters · 02/23 12:01
More
Webull provides a variety of real-time LH-WI stock news. You can receive the latest news about Laboratory Corp through multiple platforms. This information may help you make smarter investment decisions.
About LH-WI
Laboratory Corporation of America Holdings is a global life sciences company. The Company provides information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. The Company’s segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The Dx segment is an independent clinical laboratory business. It offers a menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the United States. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services. The DD segment is a contract research organizations business that provides end-to-end drug development services. The DD segment provides these services predominantly to pharmaceutical, biotechnology and medical device companies across the world. It serves clients in more than 100 countries.